Wesley McKeithan

Wesley McKeithan is a Senior Scientist at NewLimit, bringing extensive experience from roles such as Scientist II at Maze Therapeutics and Postdoctoral Scholar at University of California, San Francisco and Stanford University School of Medicine. With a background in biomedical sciences, Wesley has expertise in areas such as stem cell biology, regenerative medicine, and cardiac electrophysiology. Wesley has a PhD in Biomedical Sciences from Sanford Burnham Prebys Medical Discovery Institute Graduate School of Biomedical Sciences.